Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors

OBJECTIVE: Our aim was to assess the real‐world effectiveness of immune checkpoint inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML). METHODS: We conducted a multicenter survey compiling retrospective data from 79 PML patients, including 38 published cases an...

Descripción completa

Detalles Bibliográficos
Autores principales: Boumaza, Xavier, Bonneau, Baptiste, Roos‐Weil, Damien, Pinnetti, Carmela, Rauer, Sebastian, Nitsch, Louisa, Del Bello, Arnaud, Jelcic, Ilijas, Sühs, Kurt‐Wolfram, Gasnault, Jacques, Goreci, Yasemin, Grauer, Oliver, Gnanapavan, Sharmilee, Wicklein, Rebecca, Lambert, Nicolas, Perpoint, Thomas, Beudel, Martijn, Clifford, David, Sommet, Agnès, Cortese, Irene, Martin‐Blondel, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092874/
https://www.ncbi.nlm.nih.gov/pubmed/36151879
http://dx.doi.org/10.1002/ana.26512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092874/
https://www.ncbi.nlm.nih.gov/pubmed/36151879
http://dx.doi.org/10.1002/ana.26512

Ejemplares similares